Drugs Made In America Acquisition II Corp. Unit (DMIIU) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 10.23 |
| Open | 10.23 |
| Day High | 10.23 |
| Day Low | 10.23 |
| 52-Week High | 10.8 |
| 52-Week Low | 9.97 |
| Volume | 0 |
| Average Volume | 535 |
| Market Cap | 648.78M |
| PE | 50.25 |
| EPS | 0.2 |
| Moving Average 50 Days | 10.2 |
| Moving Average 200 Days | 10.12 |
| Change | 0 |
Data not available
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
GlobeNewswire Inc.
Dec 03, 2025 11:34 AM GMT
Fort Lauderdale, FL, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (the “Company”), a special purpose acquisition company formed as a Cayman Islands exempted company, today announced that commencing December 3, 2025,
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
GlobeNewswire Inc.
Sep 26, 2025 8:05 PM GMT
Fort Lauderdale, FL, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) today announced that it closed its initial public offering of 50,000,000 units at $10.00 per unit. The gross proceed
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
GlobeNewswire Inc.
Sep 25, 2025 10:43 AM GMT
Fort Lauderdale, FL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Drugs Made In America Acquisition II Corp. (Nasdaq: DMIIU) (the “Company”) announced today the pricing yesterday of its initial public offering of 50,000,000 units at $10.00 per unit. The uni